Sudarshan Chemical Industries Ltd (SUDARSCHEM) Q1FY27 Management Mirror - Jun-2026 Qtr
Q4 FY26 Acquired Group Business EBITDA Reported at EUR 11 Million, Against EUR 9-10 Million Prior Guidance; FY27 Target Reaffirmed at $35 Million
Management's current guidance for the acquired group in FY27 is reaffirmed at $700 million in revenue and $35 million in EBITDA, as guided in the Jun'26 Qtr concall. Despite strong Q1 FY27 performance, management chose not to revise guidance upwards due to ongoing geopolitical uncertainties, planning to revisit it at the end of Q2 FY27. Chronologically, in the Dec'25 Qtr, management guided for Q4 FY26 business EBITDA of EUR 9 million to EUR 10 million. In the subsequent Mar'26 Qtr concall, the company reported an actual Q4 FY26 acquired business Business EBITDA of EUR 11 million. During the Mar'26 Qtr, management initiated FY27 EBITDA guidance for the acquired group at EUR 35 million, alongside legacy business FY27 revenue growth guidance of 8% to 10% and an expected normalized annual depreciation run rate of approximately INR 347 crores. Over the next 3 to 4 years, management targets an acquired group EBITDA of EUR 90 million to EUR 100 million, a target initiated in the Dec'25 Qtr and reaffirmed in the Mar'26 Qtr. On a mid-term basis, the Jun'26 Qtr concall outlined a goal to reach 7 times FY23 EBITDA. For Q1 FY27, management reported consolidated revenue of INR 2,642 crores and reported EBITDA of INR 266 crores; the Quarterly Financial Results reported actual Q1 FY27 consolidated revenue of INR 2,642 crores and EBITDA of INR 259 crores.
3 more themes on the ELITE plan.